UBS ASSET MANAGEMENT AMERICAS INC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 200 filers reported holding DENALI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 9.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,271,279
+1.6%
643,300
+13.4%
0.01%0.0%
Q2 2023$13,066,9300.0%567,1410.0%0.01%0.0%
Q1 2023$13,066,930
-13.6%
567,141
+4.3%
0.01%
-25.0%
Q4 2022$15,126,502
-99.9%
543,923
+2.6%
0.01%
-11.1%
Q3 2022$16,271,961,000
+13.4%
530,204
+8.8%
0.01%
+12.5%
Q2 2022$14,344,330,000
+2.5%
487,405
+12.1%
0.01%
+33.3%
Q1 2022$13,988,384,000
-28.7%
434,827
-1.2%
0.01%
-25.0%
Q4 2021$19,625,605,000
-10.5%
440,036
+1.2%
0.01%
-11.1%
Q3 2021$21,932,331,000
-35.0%
434,734
+1.1%
0.01%
-35.7%
Q2 2021$33,719,082,000
+98.0%
429,871
+44.1%
0.01%
+75.0%
Q1 2021$17,032,017,000
-50.4%
298,284
-27.2%
0.01%
-50.0%
Q4 2020$34,315,048,000
+93.5%
409,683
-17.2%
0.02%
+60.0%
Q3 2020$17,732,518,000
+48.9%
494,907
+0.5%
0.01%
+42.9%
Q2 2020$11,912,736,000
+928.6%
492,669
+644.9%
0.01%
+600.0%
Q1 2020$1,158,128,000
+14.9%
66,141
+14.3%
0.00%0.0%
Q4 2019$1,007,833,000
+9.9%
57,855
-3.4%
0.00%0.0%
Q3 2019$917,239,000
-10.6%
59,872
+21.2%
0.00%0.0%
Q2 2019$1,025,773,000
+48.5%
49,411
+66.1%
0.00%0.0%
Q1 2019$690,678,000
+69.1%
29,745
+50.4%
0.00%
Q4 2018$408,510,000
+27.8%
19,773
+34.5%
0.00%
Q3 2018$319,578,00014,7000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders